Abstract
We evaluated a rapid antigen test against SARS-CoV-2 virus (Roche-SD Biosensor; RSDB-RAT) in children and adults with respiratory symptoms compared to those with nonrespiratory symptoms or asymptomatic. Also the performance of RSDB-RAT with respect to the duration of respiratory symptoms was assessed. A viral cross-reactivity panel was included. RSDB-RAT was reliable in detecting SARS-CoV-2 in children and adults if the respiratory symptoms had endured 1 to 7 days. If the respiratory symptoms had lasted less than 1 day, the sensitivity was significantly lower. No cross-reactivity with other respiratory viruses was observed.
| Original language | English |
|---|---|
| Article number | 115628 |
| Journal | Diagnostic Microbiology and Infectious Disease |
| Volume | 102 |
| Issue number | 4 |
| Early online date | Dec 2021 |
| DOIs | |
| Publication status | Published - Apr 2022 |
| Publication type | A1 Journal article-refereed |
Funding
The study was supported by an institutional grant of Tampere Tuberculosis Foundation (Tampere, Finland). The funder had no role of study design, data collection and interpretation, or the decision to submit the work for publication.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- COVID-19
- Rapid antigen test
- SARS-CoV-2
Publication forum classification
- Publication forum level 1
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Evaluation of the Roche-SD Biosensor rapid antigen test: Antigen is not reliable in detecting SARS-CoV-2 at the early stage of infection with respiratory symptoms'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver